Exact Sciences Plans to Raise $50.2M in Public Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences today said it plans to raise $50.2 million in net proceeds from a public offering of common stock.

The Madison, Wis.-based molecular diagnostics company is offering 5.5 million shares of its common stock at $9.75 per share. The offering is expected to close on or about Aug. 13.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.